Search clinical trials for: RO7248824

Total 2 results

Hoffmann-La Roche

Completed

A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants

Angelman Syndrome

Netherlands
Hoffmann-La Roche

Active, not recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

Angelman Syndrome

United States, Spain, Netherlands, Italy

3

Subscribe